Electrophysiologic effects of encainide on acutely ischemic rabbit myocardial cells
- PMID: 6809479
- DOI: 10.1016/0014-2999(82)90077-2
Electrophysiologic effects of encainide on acutely ischemic rabbit myocardial cells
Abstract
The electrophysiologic effects of encainide were determined in normal and acutely ischemic (30 min) rabbit ventricular muscle cells. Encainide (10(-6), 5 X 10(-6) and 10(-5) M) had no effect on resting potential (RP); 10(-6) M encainide reduced overshoot and action potential (AP) amplitude of cells in normal left ventricles and cells in normal areas of ischemic ventricles. Encainide, 5 X 10(-6) M and 10(-5) M, depressed Vmax and prolonged AP duration of normal cells. Surviving cells within ischemic areas displayed AP with reduced RP, overshoot, AP amplitude, Vmax and shortened AP duration. All encainide concentrations reduced overshoot, AP amplitude and Vmax of depressed AP. Encainide's lengthening of AP duration was greater in cells within ischemic areas than in surrounding normal cells. Encainide (10(-6) M) prolonged effective refractory period and often blocked AP in ischemic cells. Encainide also caused depression in membrane responsiveness. Encainide's differential effect upon AP may significantly contribute to its antiarrhythmic activity in ischemic heart disease.
Similar articles
-
Electrophysiologic effects of encainide following acute coronary occlusion in dogs.J Cardiovasc Pharmacol. 1981 May-Jun;3(3):532-40. doi: 10.1097/00005344-198105000-00012. J Cardiovasc Pharmacol. 1981. PMID: 6168834
-
Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):291-6. doi: 10.1097/00005344-198303000-00021. J Cardiovasc Pharmacol. 1983. PMID: 6188905
-
Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.Eur J Pharmacol. 1980 Feb 8;61(3):247-62. doi: 10.1016/0014-2999(80)90127-2. Eur J Pharmacol. 1980. PMID: 6767615
-
Basic and clinical cardiac electrophysiology of encainide.Am J Cardiol. 1986 Aug 29;58(5):18C-24C. doi: 10.1016/0002-9149(86)90099-8. Am J Cardiol. 1986. PMID: 2428230 Review.
-
Encainide: its electrophysiologic and antiarrhythmic effects, pharmacokinetics, and safety.Pharmacotherapy. 1987;7(5):149-63. doi: 10.1002/j.1875-9114.1987.tb04042.x. Pharmacotherapy. 1987. PMID: 3124082 Review.
Cited by
-
Encainide. A review of its pharmacological properties and therapeutic efficacy.Drugs. 1987 Nov;34(5):519-38. doi: 10.2165/00003495-198734050-00002. Drugs. 1987. PMID: 3121275 Review.
-
Encainide.Cardiovasc Drugs Ther. 1989 Oct;3(5):691-710. doi: 10.1007/BF01857621. Cardiovasc Drugs Ther. 1989. PMID: 2518680 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources